| Date | Title | Description |
| 03.07.2024 | Genetesis Formally Launches MICRO2 Trial with Announcement of First Patient Enrollment | MICRO2 aims to build upon early evidence demonstrating MCG's ability to aid in the noninvasive diagnosis of Coronary Microvascular Dysfunction
MASON, Ohio, July 3, 2024 /PRNewswire/ -- Genetesis, Inc., a leader in the field of magnetocardio... |
| 20.01.2023 | Genetesis Announces New Appointments to Executive Leadership Team | New additions to leadership signal commercial readiness and an expanding clinical roadmap
MASON, Ohio–(BUSINESS WIRE)–January 20, 2023–
Genetesis, Inc., the leader in biomagnetic cardiac imaging solutions, today announced the appointment of... |
| 12.10.2022 |
Genetesis closes $17.5 million Series C round | Genetesis recently announced that it has raised $17.5 million in a Series C round to further support its next-generation biomagnetic imaging technology.
Mithril Capital led the new round. There was also participation from Cercano Management... |
| 07.10.2022 | Genetesis Closes $17.5M Series C Financing | Genetesis, a Mason, OH-based biomagnetic imaging company, closed a $17.5m Series C Financing round.
The round, which brought total funding to over $40m, was led by Mithril Capital with participation from Cercano Management as well as from e... |
| 06.10.2022 | Genetesis rakes in $17.5M as its heart disease test prepares for market entry | Genetesis founder and CEO Peeyush Shrivastava describes the company as an imaging technology platform focused on delivering “the most patient-centric and cost effective solution for identifying ischemic heart disease.” On Thursday, the comp... |
| 06.10.2022 | Genetesis closes $17.5M Series C led by Mithril Capital, Cercano Management, CincyTech | - |
| 15.12.2021 | SOFTWARE AS A MEDICAL DEVICE (SaMD). Часть 2: платформы, меняющие облик индустрии цифрового здравоохранения | SOFTWARE AS A MEDICAL DEVICE (SaMD). Часть 2: платформы, меняющие облик индустрии цифрового здравоохранения |
| 15.12.2021 | SOFTWARE AS A MEDICAL DEVICE (SaMD). Part 2: Platforms that change the face of the digital health industry | SOFTWARE AS A MEDICAL DEVICE (SaMD). Part 2: Platforms that change the face of the digital health industry |
| 18.10.2021 | HEALTHTECH ARKANSAS HEALTHCARE ACCELERATOR TO INTRODUCE FIVE STARTUP COMPANIES SELECTED FOR 2021 PROGRAM WITH VIRTUAL EVENT | OPEN VIRTUAL EVENT, NOVEMBER 2, 2021 at 5:30 PM, FEATURING SECRETARY OF COMMERCE MIKE PRESTON
HealthTech Arkansas, along with 12 healthcare providers — Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health,... |
| 11.05.2020 | Genetesis Raises $9.2M in Series B Financing | Genetesis, Inc., a Mason, Ohio-based cardiac imaging company, raised $9.2M in Series B financing.
This included strategic investments from TDK Ventures and an undisclosed Fortune 500 global healthcare company, as well as return investors Ci... |
| 11.05.2020 | Genetesis Raises $9.2M in Series B |
MASON, OH, Genetesis, a cardiac imaging company, has raised $9.2M in Series B financing.
>> Click here for more funding data on Genetesis
>> To export Genetesis funding data to PDF and Excel, click here
According to FINSM... |
| 21.04.2020 | TDK Ventures Invests in Biomagnetic Medical Imaging Company Genetesis | Magnetocardiography (MCG) based technology company, Genetesis, is TDK Ventures’ fifth investment from its $50 million venture fund, and first in the healthcare space.
Ohio-based Genetesis develops advanced medical imaging solutions for card... |
| 16.08.2018 | 14 Health-Related Companies That Have Raised More Than $100K | It’s not exactly a secret that Queen City is the home to a host of startups. While there are certain trends among those represented in greater Cincinnati — such as, say, branding or consumer good — various industries have found success in t... |
| 05.06.2018 | Biomagnetic Imaging Company Genetesis Raises $7.5M in Series A | Genetesis, a Mason, OH-based medical device company focused on using biomagnetic imaging to enable rapid, noninvasive and accurate chest pain triage, closed $7.5M Series A financing.
The round was led by CincyTech with participation from ex... |
| 05.06.2018 | Genetesis noninvasive heart disease detection device attracts reinvestment from Mark Cuban’s firm in Series A | In an interview last year, Genetesis CEO and Co-founder Peeyush Shrivastava said the company’s technology is designed to address a significant public health burden.
“Where our technology fits in is we have a really high negative predictive ... |
| 05.06.2018 | Genetesis Grabs $7.5M Series A Round |
MASON, OH, Genetesis has closed an oversubscribed round of $7.5M in Series A financing.
>> Click here for more funding data on Genetesis
>> To export Genetesis funding data to PDF and Excel, click here
Genetesis, a medica... |
| 05.06.2018 | Term Sheet — Tuesday, June 5 | NEW MONEY
Good morning, Term Sheet readers.
Paid Content How can you protect what you can't see? From ExtraHop
We now know that the firm, Stride.VC, has raised approximately £40 million ($53.5 million) for its debut fund, according to TechC... |
| 17.05.2018 | UPMC, Philips, AHA, form new fund targeting cardiovascular treatment innovations | Nancy Brown, American Heart Association CEO said in the statement that the collaborative investment approach was one way to address the escalating costs of cardiovascular treatment, which the AHA projects will teeter into the $1 trillion ra... |
| 04.10.2017 | A new world of non-invasive cardiac diagnostics | CorVista is noninvasive, requires no drugs, radiation or stress testing. Clinicians place seven sensors on the patient, which collect 10 million data points in about three minutes. The data is sent to the cloud, analyzed and sent back as th... |
| 11.08.2017 | Supermodel Natalia Vodianova joins ranks of celebrity healthcare investors with women’s healthcare startup | Flo has evolved in the past year from a period tracker to include more information on ovulation and personal health insights based on the data users punch into the app, a spokeswoman for the company noted in an email. The company has also r... |
| 10.05.2017 | 6 AI startups win $1.5 million in prizes at Nvidia Inception event | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Nvidia‘s GPU Technology Conference is all about h... |
| 02.05.2017 | 50 Startups Aimed at Changing the World Join Kairos Society | Kairos Society has announced this year's Kairos 50, a collection of the 50 most innovative seed-stage companies in the world. The Kairos Society is dedicated to empowering young entrepreneurs to innovate in areas where others have remained ... |
| 23.04.2017 | Nvidia identifies the top 5 AI startups for social impact | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Nvidia is on a quest to find the best “social imp... |
| 23.04.2017 | Nvidia identifies the top 5 AI startups for social impact | Nvidia is on a quest to find the best “social impact” artificial intelligence startups as part of a program called Nvidia Inception, which is screening more than 600 entrants to cull the best AI startups in three big categories.
We wrote ab... |
| 15.11.2016 | Term Sheet — Tuesday, November 15 | ET CETERA
• The Capital of Fintech: There’s apparently a fight, or battle, or race on between cities to become the Capital of FinTech. Hubs, scenes, ecosystems “capitals,” and various spins on the phrase Silicon Valley are overrated.
Paid C... |
| 14.11.2016 | Cardiac Imaging Startup Genetesis Closes $1.2M in Seed Funding | Genetesis, a Cincinnati, OH-based medical device startup, closed a $1.2M seed financing.
The round was co-led by CincyTech and Mark Cuban’s Radical Investments, with participation from Loud Capital, Danmar Capital, Wilson Sonsini Investment... |
| - | A new world of non-invasive cardiac diagnostics | Toronto-based Analytics 4 Life just raised $25 million in Series B financing to develop and ultimately commercialize their non-invasive cardiovascular diagnostic. The device, called CorVista, reads electrical signals from the heart and, wit... |
| - | Supermodel Natalia Vodianova joins ranks of celebrity healthcare investors with women’s healthcare startup | Flo app by OWHealth
Menstrual cycle trackers tend to get mixed reviews about their accuracy but that hasn’t had much impact on the popularity of these women’s health apps. Claiming it has reached a milestone of 10 million monthly active use... |
| - | Genetesis noninvasive heart disease detection device attracts reinvestment from Mark Cuban’s firm in Series A | Genetesis, a Cincinnati-based clinical decision support business that developed a 3D mapping tool to help clinicians spot underlying cardiac disorders earlier, has closed a $7.5 million Series A round, according to a news release. The new f... |
| - | Genetesis | “Genetesis is building a better standard of care. CardioFlux is the medical device revolutionizing the world of healthcare by unlocking the body’s hidden potential.” |
| - | UPMC, Philips, AHA, form new fund targeting cardiovascular treatment innovations | University of Pittsburgh Medical Center, Philips, and the American Heart Association have banded together to start venture capital fund, Cardeation Capital. The $30 million fund, which will be managed by healthcare investment firm Aphelion ... |
